Erin L. Stewart
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 04, 2022
Assessing therapy response in patient-derived xenografts.
Journal: Science translational medicine
Published: November 17, 2021
Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 17, 2020
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.
Journal: Clinical lung cancer
Published: February 07, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 17, 2020
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 01, 2015
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.
Journal: Translational lung cancer research
Published: July 31, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026